197 related articles for article (PubMed ID: 28723880)
1. Prevalence and clinical characteristics of white-coat hypertension based on different definition criteria in untreated and treated patients.
de la Sierra A; Vinyoles E; Banegas JR; Segura J; Gorostidi M; de la Cruz JJ; Ruilope LM
J Hypertens; 2017 Dec; 35(12):2388-2394. PubMed ID: 28723880
[TBL] [Abstract][Full Text] [Related]
2. White coat effect in treated and untreated patients with high office blood pressure. Relationship with pulse wave velocity and left ventricular mass index.
Silveira A; Mesquita A; Maldonado J; Silva JA; Polónia J
Rev Port Cardiol; 2002 May; 21(5):517-30. PubMed ID: 12174516
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic criteria of white coat hypertension (WCH): consequences for the implications of WCH for target organs.
Pose-Reino A; Rodríguez-Fernández M; López-Barreiro L; Coleman IC; Estévez-Nuñez JC; Méndez-Naya I
Blood Press; 2002; 11(3):144-50. PubMed ID: 12126260
[TBL] [Abstract][Full Text] [Related]
4. Long-term prognostic value of white coat hypertension: an insight from diagnostic use of both ambulatory and home blood pressure measurements.
Mancia G; Bombelli M; Brambilla G; Facchetti R; Sega R; Toso E; Grassi G
Hypertension; 2013 Jul; 62(1):168-74. PubMed ID: 23716584
[TBL] [Abstract][Full Text] [Related]
5. White Coat Hypertension: to Treat or Not to Treat?
Cuspidi C; Sala C; Grassi G; Mancia G
Curr Hypertens Rep; 2016 Nov; 18(11):80. PubMed ID: 27787835
[TBL] [Abstract][Full Text] [Related]
6. Nocturnal blood pressure: the dark side of white-coat hypertension.
Cuspidi C; Paoletti F; Tadic M; Sala C; Gherbesi E; Dell'Oro R; Grassi G; Mancia G
J Hypertens; 2020 Dec; 38(12):2404-2408. PubMed ID: 32649631
[TBL] [Abstract][Full Text] [Related]
7. Nighttime mean arterial pressure is associated with left ventricular hypertrophy in white-coat hypertension.
Yang X; Yuan Y; Gou Q; Ye R; Li X; Li J; Ma J; Li Y; Chen X
J Clin Hypertens (Greenwich); 2022 Aug; 24(8):1035-1043. PubMed ID: 35791888
[TBL] [Abstract][Full Text] [Related]
8. Adverse prognostic value of persistent office blood pressure elevation in white coat hypertension.
Mancia G; Facchetti R; Grassi G; Bombelli M
Hypertension; 2015 Aug; 66(2):437-44. PubMed ID: 26056342
[TBL] [Abstract][Full Text] [Related]
9. Sequential follow-up clinic and ambulatory blood pressure evaluation in a low risk population of white-coat hypertensive patients and in normotensives.
Polónia JJ; Gama GM; Silva JA; Amaral C; Martins LR; Bertoquini SE
Blood Press Monit; 2005 Apr; 10(2):57-64. PubMed ID: 15812251
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring.
Ríos MT; Domínguez-Sardiña M; Ayala DE; Gomara S; Sineiro E; Pousa L; Callejas PA; Fontao MJ; Fernández JR; Hermida RC;
Chronobiol Int; 2013 Mar; 30(1-2):207-20. PubMed ID: 23077975
[TBL] [Abstract][Full Text] [Related]
11. Ambulatory blood pressure measurement in the main cities of Cameroon: prevalence of masked and white coat hypertension, and influence of body mass index.
Takah N; Dzudie A; Ndjebet J; Wawo G; Kamdem F; Monkam Y; Luma H; Ngu KB; Kengne AP
Pan Afr Med J; 2014; 19():240. PubMed ID: 25848455
[TBL] [Abstract][Full Text] [Related]
12. Office blood pressure is a predictor of aortic elastic properties and urinary protein excretion in subjects with white coat hypertension.
Aznaouridis K; Vlachopoulos C; Masoura K; Pietri P; Vyssoulis G; Ioakeimidis N; Stefanadis C; Tousoulis D
Int J Cardiol; 2016 Jan; 203():98-103. PubMed ID: 26498870
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of white coat hypertension in Chinese Han patients with type 2 diabetes mellitus.
Zhou J; Liu C; Shan P; Zhou Y; Xu E; Ji Y
Clin Exp Hypertens; 2014; 36(5):321-5. PubMed ID: 24047449
[TBL] [Abstract][Full Text] [Related]
14. The Cardiovascular Risk of White-Coat Hypertension.
Franklin SS; Thijs L; Asayama K; Li Y; Hansen TW; Boggia J; Jacobs L; Zhang Z; Kikuya M; Björklund-Bodegård K; Ohkubo T; Yang WY; Jeppesen J; Dolan E; Kuznetsova T; Stolarz-Skrzypek K; Tikhonoff V; Malyutina S; Casiglia E; Nikitin Y; Lind L; Sandoya E; Kawecka-Jaszcz K; Filipovský J; Imai Y; Wang JG; O'Brien E; Staessen JA;
J Am Coll Cardiol; 2016 Nov; 68(19):2033-2043. PubMed ID: 27810041
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and clinical correlates of white coat hypertension in chronic kidney disease.
Minutolo R; Borrelli S; Scigliano R; Bellizzi V; Chiodini P; Cianciaruso B; Nappi F; Zamboli P; Conte G; De Nicola L
Nephrol Dial Transplant; 2007 Aug; 22(8):2217-23. PubMed ID: 17420167
[TBL] [Abstract][Full Text] [Related]
16. White-coat hypertension from a paediatric perspective.
Krmar RT
Acta Paediatr; 2019 Jan; 108(1):44-49. PubMed ID: 29797349
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of white coat hypertension in children: importance of the definitions of normal ambulatory blood pressure and the severity of casual hypertension.
Sorof JM; Poffenbarger T; Franco K; Portman R
Am J Hypertens; 2001 Sep; 14(9 Pt 1):855-60. PubMed ID: 11587149
[TBL] [Abstract][Full Text] [Related]
18. White-Coat and Reverse White-Coat Effects Correlate with 24-h Pulse Pressure and Systolic Blood Pressure Variability in Children and Young Adults.
Fujita H; Matsuoka S; Awazu M
Pediatr Cardiol; 2016 Feb; 37(2):345-52. PubMed ID: 26481222
[TBL] [Abstract][Full Text] [Related]
19. [Predictive factors of hypertension in patients with diagnostic doubts of persistent hypertension].
Mediavilla García JD; Sabio JM; Carrillo Alascio PL; Fernández Torres C; Aliaga Martínez L; Jiménez-Alonso J
Med Clin (Barc); 2002 Oct; 119(11):401-4. PubMed ID: 12381272
[TBL] [Abstract][Full Text] [Related]
20. Relationships between cardiovascular risk factors and white-coat hypertension diagnosed by home blood pressure recordings in a middle-aged population.
Johansson MAK; Östgren CJ; Engvall J; Swahn E; Wijkman M; Nystrom FH
J Hypertens; 2021 Oct; 39(10):2009-2014. PubMed ID: 33973957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
